Home › NDC Lookup › RxCUI directory › RxCUI 422410

Midazolam 2 MG/ML Oral Solution — RxCUI 422410

RxNorm drug concept · Semantic clinical drug
RxCUI 422410 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI422410
Official nameMidazolam 2 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmidazolam 10 MG per 5 ML Oral Solution; midazolam 10 MG in 5 mL Oral Solution; midazolam (as midazolam hydrochloride) 10 MG per 5 ML Syrup; midazolam (as midazolam hydrochloride) 2 MG/ML Syrup
FDA products mapped6
Package NDCs mapped7
Reported Medicaid activity (SDUD)5,415 prescriptions · 23 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Midazolam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the form. Injections and the children's syrup are used to calm you, ease anxiety and block memory around procedures or surgery. Injections are also used for anesthesi...
  • Injections and the syrup are given by trained staff in monitored settings. The syrup is a single dose before a procedure, not for home use. Nayzilam is sprayed into one nostril, wi...
  • Drowsiness, nausea, vomiting and trouble remembering things for several hours are common. Blood pressure may dip slightly. Slow or shallow breathing, severe sleepiness or agitation...
  • No, avoid them unless your prescriber says otherwise. Alcohol and opioids can cause dangerously slow breathing, coma and death. Tell your team about every medicine you take, includ...
📖 Read our full Midazolam guide →

🕸️ Concept Web — How Midazolam 2 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Midazolam 2 MG/ML Oral Solution RxCUI 422410

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Midazolam 6960
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Midazolam Oral Solution 446503
    • Midazolam Oral Liquid Product 1164716
    • Midazolam Oral Product 1164717
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Midazolam 2 MG/ML 330380

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Midazolam 2 MG/ML SCDC · 330380
  • Midazolam Oral Solution SCDF · 446503
  • Midazolam Oral Liquid Product SCDG · 1164716
  • Midazolam Oral Product SCDG · 1164717

📦 FDA Products & Package NDCs

6 products · 7 package NDCs
7 package NDCs map to RxCUI 422410 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-3566-99 118 mL in 1 BOTTLE, GLASS (0054-3566-99) Midazolam Hydrochloride Hikma Pharmaceuticals USA Inc. 2002-04-30
00574-0150-04 1 BOTTLE, GLASS in 1 CARTON (0574-0150-04) / 118 mL in 1 BO... Midazolam Hydrochloride Padagis US LLC 2005-05-02
60687-0576-10 3 TRAY in 1 CASE (60687-576-10) / 10 CUP, UNIT-DOSE in 1 TR... Midazolam Hydrochloride American Health Packaging 2021-06-15
60687-0576-86 3 TRAY in 1 CASE (60687-576-86) / 10 CUP, UNIT-DOSE in 1 TR... Midazolam Hydrochloride American Health Packaging 2021-06-15
68094-0762-62 3 TRAY in 1 CASE (68094-762-62) / 10 CUP, UNIT-DOSE in 1 TR... Midazolam Hydrochloride Precision Dose Inc. 2015-05-26
68094-0764-62 3 TRAY in 1 CASE (68094-764-62) / 10 CUP, UNIT-DOSE in 1 TR... Midazolam Hydrochloride Precision Dose Inc. 2015-05-26
72162-1109-02 1 BOTTLE, GLASS in 1 CARTON (72162-1109-2) / 118 mL in 1 BO... Midazolam Hydrochloride Bryant Ranch Prepack 2023-10-25
Observed labelers: American Health Packaging (2) · Precision Dose Inc. (2) · Bryant Ranch Prepack (1) · Hikma Pharmaceuticals USA Inc. (1) · Padagis US LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.6871
Range $0.6871–$0.6871 · middle 50% $0.6871–$0.6871 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.